Antigen presentation abrogated in cells expressing truncated Ia molecules. 1989

N Nabavi, and Z Ghogawala, and A Myer, and I J Griffith, and W F Wade, and Z Z Chen, and D J McKean, and L H Glimcher
Department of Cancer Biology, Harvard School of Public Health, Boston, MA 02115.

Oligonucleotide site-directed mutagenesis was used to introduce a premature stop codon in wildtype A beta k and A alpha k cDNA clones to create truncated A beta k and A alpha k molecules lacking the cytoplasmic domain. Transfected B lymphoma cells expressing an I-Ak molecule with a truncated beta-chain or with truncated alpha- and beta-chains showed profound defects in two Ia-related functions: Ia-restricted Ag presentation and intracytoplasmic signaling. The ability of these transfected cell lines to activate autoreactive T hybrids was markedly impaired whereas loss of Ag presentation to nominal Ag-specific T hybrids was more subtle. Ia-mediated transmembrane signaling as measured by PKC translocation from cytosol to nucleus after stimulation with anti-Ak antibody was greatly affected by truncation of the A beta and A alpha cytoplasmic domains. These results indicate an important role for the highly conserved cytoplasmic domain in Ia-mediated responses.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000938 Antigen-Presenting Cells A heterogeneous group of immunocompetent cells that mediate the cellular immune response by processing and presenting antigens to the T-cells. Traditional antigen-presenting cells include MACROPHAGES; DENDRITIC CELLS; LANGERHANS CELLS; and B-LYMPHOCYTES. FOLLICULAR DENDRITIC CELLS are not traditional antigen-presenting cells, but because they hold antigen on their cell surface in the form of IMMUNE COMPLEXES for B-cell recognition they are considered so by some authors. Accessory Cells, Immunologic,Antigen-Presenting Cell,Immunologic Accessory Cells,Accessory Cell, Immunologic,Cell, Immunologic Accessory,Cells, Immunologic Accessory,Immunologic Accessory Cell,Antigen Presenting Cell,Antigen Presenting Cells,Cell, Antigen-Presenting,Cells, Antigen-Presenting

Related Publications

N Nabavi, and Z Ghogawala, and A Myer, and I J Griffith, and W F Wade, and Z Z Chen, and D J McKean, and L H Glimcher
January 1989, International immunology,
N Nabavi, and Z Ghogawala, and A Myer, and I J Griffith, and W F Wade, and Z Z Chen, and D J McKean, and L H Glimcher
April 1995, International immunology,
N Nabavi, and Z Ghogawala, and A Myer, and I J Griffith, and W F Wade, and Z Z Chen, and D J McKean, and L H Glimcher
May 1987, The American journal of pathology,
N Nabavi, and Z Ghogawala, and A Myer, and I J Griffith, and W F Wade, and Z Z Chen, and D J McKean, and L H Glimcher
March 1985, Journal of immunology (Baltimore, Md. : 1950),
N Nabavi, and Z Ghogawala, and A Myer, and I J Griffith, and W F Wade, and Z Z Chen, and D J McKean, and L H Glimcher
January 2002, Nature immunology,
N Nabavi, and Z Ghogawala, and A Myer, and I J Griffith, and W F Wade, and Z Z Chen, and D J McKean, and L H Glimcher
October 1990, Journal of immunology (Baltimore, Md. : 1950),
N Nabavi, and Z Ghogawala, and A Myer, and I J Griffith, and W F Wade, and Z Z Chen, and D J McKean, and L H Glimcher
March 1979, Investigative ophthalmology & visual science,
N Nabavi, and Z Ghogawala, and A Myer, and I J Griffith, and W F Wade, and Z Z Chen, and D J McKean, and L H Glimcher
August 1986, Proceedings of the National Academy of Sciences of the United States of America,
N Nabavi, and Z Ghogawala, and A Myer, and I J Griffith, and W F Wade, and Z Z Chen, and D J McKean, and L H Glimcher
April 1990, Science (New York, N.Y.),
N Nabavi, and Z Ghogawala, and A Myer, and I J Griffith, and W F Wade, and Z Z Chen, and D J McKean, and L H Glimcher
February 1987, Clinical and experimental immunology,
Copied contents to your clipboard!